Hereditary Cancer In Clinical Practice

Journal Title：Hereditary Cancer In Clinical Practice

Hereditary Cancer in Clinical Practice is an open access journal that publishes articles of interest for the cancer genetics community and serves as a discussion forum for the development appropriate healthcare strategies.

Cancer genetics encompasses a wide variety of disciplines and knowledge in the field is rapidly growing, especially as the amount of information linking genetic differences to inherited cancer predispositions continues expanding. With the increased knowledge of genetic variability and how this relates to cancer risk there is a growing demand not only to disseminate this information into clinical practice but also to enable competent debate concerning how such information is managed and what it implies for patient care.

Topics covered by the journal include but are not limited to:

Original research articles on any aspect of inherited predispositions to cancer.

Reviews of inherited cancer predispositions.

Application of molecular and cytogenetic analysis to clinical decision making.

Clinical aspects of the management of hereditary cancers.

Genetic counselling issues associated with cancer genetics.

The role of registries in improving health care of patients with an inherited predisposition to cancer.

《临床实践中的遗传性癌症》是一本开放获取期刊，发表癌症遗传学界感兴趣的文章，并作为制定适当医疗保健策略的讨论论坛。

癌症遗传学涵盖了各种各样的学科，该领域的知识正在迅速增长，特别是随着将遗传差异与遗传性癌症倾向联系起来的信息量不断增加。随着对遗传变异及其与癌症风险关系的了解不断增加，不仅需要将这些信息传播到临床实践中，还需要就如何管理这些信息以及这些信息对患者护理意味着什么展开有力的辩论。

该期刊涵盖的主题包括但不限于：

关于遗传性癌症易感性任何方面的原创研究文章。

遗传性癌症易感性评论。

分子和细胞遗传学分析在临床决策中的应用。

遗传性癌症管理的临床方面。

与癌症遗传学相关的遗传咨询问题。

登记处在改善具有遗传性癌症易感性患者的医疗保健方面的作用。

Hereditary Cancer In Clinical Practice创刊于2003年，由BioMed Central出版商出版，收稿方向涵盖医学 - 肿瘤学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 12周，或约稿 ，影响因子指数2，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。